PATENT CLAIM ANALYSIS

Application Number: 16302158
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["514", "210180"]

Abstract:
The present invention provides compounds of Formula (I): as defined in the specification and compositions comprising any of such novel compounds. These compounds are endothelial lipase inhibitors which may be used as medicament.

Claim (Index 18):
A method of treating a disease, disorder, or condition associated with dysregulation of endothelial lipase in a patient in need thereof comprising administering a therapeutically effective amount of a compound according to  claim 1 , or a stereoisomer, a tautomer, or a pharmaceutically acceptable salt or solvate thereof, to the patient.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 98.0
- Lexical Diversity: 1.15152
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13936311', '13944921', '14427105', '14346745', '14390152']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.743965333362473
- 35 USC 102 Novelty (BERT): 0.5276276978149765
- Combined Prediction Score: 0.7223315698077233
- Mean Citation Score: 302.8511640000001
- Max Citation Score: 311.87286
- Similarity Product: 199.90157202928663

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test